Apyx Medical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Dec 23 | BuyUS$5,475 | Matthew Hill | Individual | 2,500 | US$2.19 | |
14 Nov 23 | BuyUS$78,500 | Charles Goodwin | Individual | 50,000 | US$1.57 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,135 | 0.0119% |
Hedge Funds | 3,452,030 | 9.96% |
Individual Insiders | 4,462,381 | 12.9% |
Institutions | 11,721,695 | 33.8% |
General Public | 15,003,685 | 43.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,452,030 | US$4.9m | 0% | 1.85% | |||
3,158,414 | US$4.5m | 0% | no data | |||
2,158,900 | US$3.0m | 0% | 0.02% | |||
1,480,884 | US$2.1m | 0.07% | no data | |||
1,025,963 | US$1.4m | -42.3% | 0.02% | |||
638,965 | US$900.9k | 2.87% | 0.38% | |||
624,389 | US$880.4k | 0% | no data | |||
615,000 | US$867.1k | 0% | 0.01% | |||
613,880 | US$865.6k | 0% | 0.78% | |||
608,628 | US$858.2k | 44.5% | no data | |||
605,682 | US$854.0k | 0% | 0.35% | |||
497,555 | US$701.6k | -0.17% | no data | |||
456,504 | US$643.7k | 0% | no data | |||
370,503 | US$522.4k | -8.38% | no data | |||
349,193 | US$492.4k | 8.67% | no data | |||
309,817 | US$436.8k | 2.75% | no data | |||
292,424 | US$412.3k | -3.11% | 0.05% | |||
264,454 | US$372.9k | -42.5% | no data | |||
213,500 | US$301.0k | 0.8% | 0.23% | |||
187,485 | US$264.4k | -25.6% | no data | |||
163,100 | US$230.0k | 0% | no data | |||
157,898 | US$222.6k | -0.24% | no data | |||
125,376 | US$176.8k | 60.2% | no data | |||
107,706 | US$151.9k | 0% | no data | |||
101,334 | US$142.9k | 0% | no data |